Causality Assessment for Suspected Drug-Induced Liver Injury in Patients With Underlying Chronic Liver Disease

dc.contributor.authorDakhoul, Lara
dc.contributor.authorChalasani, Naga
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2019-08-01T17:11:19Z
dc.date.available2019-08-01T17:11:19Z
dc.date.issued2017-03-30
dc.identifier.citationDakhoul, L., & Chalasani, N. (2017). Causality Assessment for Suspected Drug-Induced Liver Injury in Patients With Underlying Chronic Liver Disease. Clinical liver disease, 9(3), 63–65. doi:10.1002/cld.619en_US
dc.identifier.urihttps://hdl.handle.net/1805/20097
dc.language.isoen_USen_US
dc.publisherWileyen_US
dc.relation.isversionof10.1002/cld.619en_US
dc.relation.journalClinical Liver Diseaseen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectDrug‐induced liver injury (DILI)en_US
dc.subjectLiver diseaseen_US
dc.subjectChronic liver diseaseen_US
dc.subjectNonalcoholic fatty liver disease (NAFLD)en_US
dc.titleCausality Assessment for Suspected Drug-Induced Liver Injury in Patients With Underlying Chronic Liver Diseaseen_US
dc.typeArticleen_US
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467144/en_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
CLD-9-63.pdf
Size:
89.1 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: